CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+6.21%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$907M
AUM Growth
+$907M
(+28%)
Cap. Flow
+$198M
Cap. Flow
% of AUM
21.86%
Top 10 Holdings %
Top 10 Hldgs %
37.32%
Holding
435
New
22
Increased
337
Reduced
40
Closed
7
Top Buys
| 1 |
Apple
AAPL
|
$25.8M |
| 2 |
Broadcom
AVGO
|
$24.2M |
| 3 |
Microsoft
MSFT
|
$10.9M |
| 4 |
Amgen
AMGN
|
$7.28M |
| 5 |
NVIDIA
NVDA
|
$6.87M |
Top Sells
| 1 |
Micron Technology
MU
|
$6.44M |
| 2 |
ServiceNow
NOW
|
$5.1M |
| 3 |
Salesforce
CRM
|
$5M |
| 4 |
CrowdStrike
CRWD
|
$4.33M |
| 5 |
Qualcomm
QCOM
|
$3.38M |
Sector Composition
| 1 | Technology | 37.6% |
| 2 | Healthcare | 28.11% |
| 3 | Consumer Discretionary | 12.57% |
| 4 | Communication Services | 9.53% |
| 5 | Consumer Staples | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Under Armour
UAA
$2.16B
| $576K | 0.06% |
+64,600
| New | +$576K |
|
202
Xenon Pharmaceuticals
XENE
$3.03B
| $574K | 0.06% |
14,572
+5,704
| +64% | +$225K |
|
203
PTC Therapeutics
PTCT
$4.16B
| $549K | 0.06% |
14,795
+5,783
| +64% | +$215K |
|
204
Iovance Biotherapeutics
IOVA
$792M
| $548K | 0.06% |
58,376
+25,500
| +78% | +$239K |
|
205
Microchip Technology
MCHP
$34.3B
| $546K | 0.06% |
6,805
+3,577
| +111% | +$287K |
|
206
GE HealthCare
GEHC
$32.7B
| $544K | 0.06% |
5,792
+3,048
| +111% | +$286K |
|
207
Guardant Health
GH
$8.29B
| $543K | 0.06% |
23,661
+9,283
| +65% | +$213K |
|
208
Old Dominion Freight Line
ODFL
$31.5B
| $540K | 0.06% |
2,718
+1,412
| +108% | +$280K |
|
209
Kraft Heinz
KHC
$30.8B
| $538K | 0.06% |
15,336
+8,035
| +110% | +$282K |
|
210
Geron
GERN
$938M
| $526K | 0.06% |
115,937
+46,254
| +66% | +$210K |
|
211
Fastenal
FAST
$56.5B
| $519K | 0.06% |
7,263
+3,821
| +111% | +$273K |
|
212
IDEAYA Biosciences
IDYA
$2.23B
| $515K | 0.06% |
16,249
+7,356
| +83% | +$233K |
|
213
Exelon
EXC
$43.8B
| $515K | 0.06% |
12,690
+6,677
| +111% | +$271K |
|
214
Protagonist Therapeutics
PTGX
$3.66B
| $510K | 0.06% |
11,329
+4,438
| +64% | +$200K |
|
215
Twist Bioscience
TWST
$1.58B
| $509K | 0.06% |
11,268
+4,427
| +65% | +$200K |
|
216
Apogee Therapeutics
APGE
$2.26B
| $508K | 0.06% |
8,655
+3,371
| +64% | +$198K |
|
217
Structure Therapeutics
GPCR
$1.16B
| $503K | 0.06% |
11,460
+5,707
| +99% | +$250K |
|
218
Veracyte
VCYT
$2.37B
| $503K | 0.06% |
14,773
+5,790
| +64% | +$197K |
|
219
ImmunityBio
IBRX
$2.25B
| $498K | 0.05% |
133,966
+52,716
| +65% | +$196K |
|
220
Acadia Pharmaceuticals
ACAD
$4.33B
| $491K | 0.05% |
31,903
+12,493
| +64% | +$192K |
|
221
Agios Pharmaceuticals
AGIO
$2.28B
| $486K | 0.05% |
10,942
+4,272
| +64% | +$190K |
|
222
Cognizant
CTSH
$35.1B
| $485K | 0.05% |
6,287
+3,298
| +110% | +$255K |
|
223
Verisk Analytics
VRSK
$37B
| $484K | 0.05% |
1,807
+949
| +111% | +$254K |
|
224
Edgewise Therapeutics
EWTX
$1.57B
| $481K | 0.05% |
18,035
+7,062
| +64% | +$188K |
|
225
Electronic Arts
EA
$42.9B
| $481K | 0.05% |
3,351
+1,749
| +109% | +$251K |
|